ES2132351T3 - Compuestos con un grupo sulfamoilo y amidino, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. - Google Patents
Compuestos con un grupo sulfamoilo y amidino, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.Info
- Publication number
- ES2132351T3 ES2132351T3 ES94400331T ES94400331T ES2132351T3 ES 2132351 T3 ES2132351 T3 ES 2132351T3 ES 94400331 T ES94400331 T ES 94400331T ES 94400331 T ES94400331 T ES 94400331T ES 2132351 T3 ES2132351 T3 ES 2132351T3
- Authority
- ES
- Spain
- Prior art keywords
- linked
- represent
- alkilo
- phenyl
- eventually
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001409 amidines Chemical group 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- -1 ISOQUINOLYL Chemical class 0.000 abstract 3
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- KZKRRZFCAYOXQE-UHFFFAOYSA-N 1$l^{2}-azinane Chemical class C1CC[N]CC1 KZKRRZFCAYOXQE-UHFFFAOYSA-N 0.000 abstract 1
- ZITFWUUYPONCCK-UHFFFAOYSA-N 1,2,3,4,5,6-hexachlorocyclohexane;naphthalen-1-yl n-methylcarbamate Chemical class ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl.C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 ZITFWUUYPONCCK-UHFFFAOYSA-N 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical compound C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- ZBJJDYGJCNTNTH-UHFFFAOYSA-N Betahistine mesilate Chemical compound CS(O)(=O)=O.CS(O)(=O)=O.CNCCC1=CC=CC=N1 ZBJJDYGJCNTNTH-UHFFFAOYSA-N 0.000 abstract 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical class NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical group [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen(.) Chemical compound [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 210000001428 peripheral nervous system Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA I EN LA QUE AR1 REPRESENTA NAFTILO, FENILO, QUINOLILO O ISOQUINOLILO EVENTUALMENTE SUSTITUIDO; AR2 REPRESENTA FENILO O TIENILO, EVENTUALMENTE SUSTITUIDOS; R1, R2 Y R''2 REPRESENTAN INDEPENDIENTEMENTE UNO DEL OTRO H, (C1-C4)ALKILO O R1 NO REPRESENTA NADA Y N ESTA LIGADO A AR2 Y EVENTUALMENTE R2 Y R''2 FORMAN UN DOBLE ENLACE, O R1 O R2 ESTA LIGADO A AR2 Y REPRESENTA (C1-C3)ALKILENO; R3 Y R4 IDENTICOS O DIFERENTES, REPRESENTAN H, (C1-C4)ALKILO O FORMAN CON EL ATOMO DE NITROGENO AL QUE ESTAN LIGADOS UN HETEROCICLO SATURADO EN (C2-C7); Z1 REPRESENTA (C1C12) ALKILENO; Q1 REPRESENTA METILO, AMINO, (C1C4)ALCOXICARBONILAMINO, (C1-C4)ALKILAMINO, (D(C1-C4)ALKILAMINO, PIRROLIDINILO, PIPERIDINO, MORFOLINO, PIPERAZINILO, (C1-C4)ALKIL4 PIPERAZINILO, AMIDINO, (C1-C4)ALKILAMIDINO, GUANIDINO, (C1C4)ALKILGUANIDINO, PIRIDILO, IMIDAZOLILO, PIRIMIDINILO, INDOLILO, HIDROXI, (C1-C4)ALCOXI, (C2-C8)ALCOXICARBONILO, AMINO(C1C4)ALKIL-N-(C1-C4)ALKILAMINO, CARBAMOILO O FENILO EVENTUALMENTE SUSTITUIDO; Q2 REPRESENTA H O (C1-C4)ALKILO; Q3 REPRESENTA H O (C1-C4)ALKILO O Q1 Y Q3 ESTAN LIGADO PARA FORMAR UN HETEROCICLO Y REPRESENTAN JUNTOS (C2-C3)ALKILENO MIENTRAS QUE Z1 NO REPRESENTA NADA, EN FORMA DE ENANTIOMEROS PUROS O DE SUS MEZCLAS EN CUALQUIER PROPORCION, ASI COMO SUS SALES CON ACIDOS. ESTOS COMPUESTOS TIENEN UNA AFINIDAD PARA LOS RECEPTORES BIOLOGICOS DE NEUROPEPTIDO Y (NPY), PRESENTES E EL SISTEMA NERVIOSO CENTRAL Y PERIFERICO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9301686A FR2701480B1 (fr) | 1993-02-15 | 1993-02-15 | Composés à groupe sulfamoyle et amidino, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2132351T3 true ES2132351T3 (es) | 1999-08-16 |
Family
ID=9444071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94400331T Expired - Lifetime ES2132351T3 (es) | 1993-02-15 | 1994-02-15 | Compuestos con un grupo sulfamoilo y amidino, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. |
Country Status (23)
Country | Link |
---|---|
US (2) | US5506258A (es) |
EP (1) | EP0614911B1 (es) |
JP (1) | JP2994546B2 (es) |
KR (1) | KR940019682A (es) |
CN (1) | CN1104634A (es) |
AT (1) | ATE179430T1 (es) |
AU (1) | AU673398B2 (es) |
CA (1) | CA2115631A1 (es) |
DE (1) | DE69418083T2 (es) |
DK (1) | DK0614911T3 (es) |
ES (1) | ES2132351T3 (es) |
FI (1) | FI940680A (es) |
FR (1) | FR2701480B1 (es) |
GR (1) | GR3030243T3 (es) |
HU (1) | HUT66960A (es) |
IL (1) | IL108649A (es) |
MX (1) | MX9401191A (es) |
NO (1) | NO304313B1 (es) |
NZ (1) | NZ250878A (es) |
PH (1) | PH30887A (es) |
RU (1) | RU2126382C1 (es) |
TW (1) | TW372233B (es) |
ZA (1) | ZA941029B (es) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5516653A (en) * | 1993-12-28 | 1996-05-14 | Synaptic Pharmaceutical Corporation | DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof |
US5545549A (en) * | 1994-02-03 | 1996-08-13 | Synaptic Pharmaceutical Corporation | DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof |
US5602024A (en) | 1994-12-02 | 1997-02-11 | Synaptic Pharmaceutical Corporation | DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
US5989920A (en) | 1994-12-02 | 1999-11-23 | Synaptic Pharmaceutical Corporation | Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5 |
US5668151A (en) * | 1995-06-07 | 1997-09-16 | Bristol-Myers Squibb Company | Dihydropyridine NPY antagonists: piperidine derivatives |
DK0861236T4 (da) * | 1995-11-13 | 2006-12-18 | Sanofi Aventis Deutschland | Cykliske og heterocykliske N-substituerede alphaiminohydroxam- og carboxylsyrer |
WO1997020823A2 (en) * | 1995-12-01 | 1997-06-12 | Novartis Ag | 2-amino quinazoline derivatives as npy receptor antagonists |
WO1997019682A1 (en) | 1995-12-01 | 1997-06-05 | Synaptic Pharmaceutical Corporation | Aryl sulfonamide and sulfamide derivatives and uses thereof |
WO1997020822A1 (en) * | 1995-12-01 | 1997-06-12 | Novartis Ag | Quinazolin-2,4-diazirines as npy receptor antagonist |
US6433185B1 (en) | 1996-01-11 | 2002-08-13 | Sanofi-Synthelabo | N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them |
FR2743562B1 (fr) * | 1996-01-11 | 1998-04-03 | Sanofi Sa | Derives de n-(arylsulfonyl) aminoacides, leur preparation, les compositions pharmaceutiques en contenant |
AU2042897A (en) * | 1996-03-21 | 1997-10-10 | Banyu Pharmaceutical Co., Ltd. | Aminopyridine derivatives |
DK0984778T3 (da) | 1996-08-23 | 2002-09-16 | Agouron Pharma | Neuropeptid-Y-ligander |
FR2754709B1 (fr) | 1996-10-23 | 1999-03-05 | Sanofi Sa | Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition |
AU6144098A (en) * | 1997-02-14 | 1998-09-08 | Bayer Corporation | Amide derivatives as selective neuropeptide y receptor antagonists |
US6048900A (en) | 1998-02-13 | 2000-04-11 | Bayer Corporation | Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists |
US6245817B1 (en) | 1997-02-14 | 2001-06-12 | Bayer Corporation | NPY5 receptor antagonists and methods for using same |
DE19719817A1 (de) * | 1997-05-13 | 1998-11-19 | Hoechst Ag | Substituierte 6- und 7-Aminotetrahydroisochinolincarbonsäuren |
US6713265B1 (en) | 1997-06-04 | 2004-03-30 | Synaptic Pharmaceutical Corporation | Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
US5889016A (en) * | 1997-06-26 | 1999-03-30 | Bristol-Myers Squibb Company | Dihydropyrimidone derivatives as NPY antagonists |
CO5011105A1 (es) * | 1997-12-22 | 2001-02-28 | Novartis Ag | Compuestos organicos para tratar la obesidad y desordenes relacionados, composiciones farmaceuticas que los comprenden y procesos para su preparacion |
GB2344050A (en) * | 1998-11-26 | 2000-05-31 | Ferring Bv | Agents useful in the treatment of reproductive disorders. |
FR2819254B1 (fr) * | 2001-01-08 | 2003-04-18 | Fournier Lab Sa | Nouveaux composes de la n-(phenylsulfonyl) glycine, leur procede de preparation et leur utilisation pour obtenir des compostions pharmaceutiques |
FR2822827B1 (fr) * | 2001-03-28 | 2003-05-16 | Sanofi Synthelabo | Nouveaux derives de n-(arylsulfonyl) beta-aminoacides comportant un groupe aminomethyle substitue, leur procede de preparation et les compositions pharmaceutiques en contenant |
AU2002314744A1 (en) * | 2001-04-17 | 2002-10-28 | Sepracor, Inc. | Thiazole and other heterocyclic ligands and use thereof |
GB0130219D0 (en) * | 2001-12-18 | 2002-02-06 | Pfizer Ltd | Compounds for the treatment of sexual dysfunction |
FR2840897B1 (fr) | 2002-06-14 | 2004-09-10 | Fournier Lab Sa | Nouveaux derives d'arylsulfonamides et leur utilisation en therapeutique |
JP4593559B2 (ja) * | 2003-03-25 | 2010-12-08 | ラボラトワール フルニエ エス・アー | ベンゼンスルホンアミド誘導体、その製造方法、及び、痛みを治療するためのその使用 |
DE602004026289D1 (de) | 2003-05-05 | 2010-05-12 | Probiodrug Ag | Glutaminylcyclase-hemmer |
DE10344936A1 (de) * | 2003-09-27 | 2005-04-21 | Aventis Pharma Gmbh | Bicyclische Iminosäurederivate als Inhibitoren von Matrix-Metalloproteinasen |
ZA200603165B (en) | 2003-11-03 | 2007-07-25 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
AU2005210004B2 (en) | 2004-02-05 | 2010-10-28 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
WO2008065141A1 (en) | 2006-11-30 | 2008-06-05 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
ZA200905537B (en) | 2007-03-01 | 2010-10-27 | Probiodrug Ag | New use of glutaminyl cyclase inhibitors |
JP5667440B2 (ja) | 2007-04-18 | 2015-02-12 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体 |
MX2009011615A (es) * | 2007-06-05 | 2009-11-10 | Sanofi Aventis | Acidos benzoilamino-indan-2-carboxilicos sustituidos y compuestos relacionados. |
CA2714617A1 (en) | 2008-03-06 | 2009-09-11 | Banyu Pharmaceutical Co., Ltd. | Alkylaminopyridine derivative |
FR2949674A1 (fr) * | 2009-09-10 | 2011-03-11 | Oreal | Utilisation d'un antagoniste du neuropeptide y pour augmenter le volume et/ou la coloration naturelle des levres |
MX2012002993A (es) | 2009-09-11 | 2012-04-19 | Probiodrug Ag | Derivados heterociclicos como inhibidores de ciclasa glutaminilo. |
JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
MX2012010470A (es) | 2010-03-10 | 2012-10-09 | Probiodrug Ag | Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5). |
US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
WO2012123563A1 (en) | 2011-03-16 | 2012-09-20 | Probiodrug Ag | Benz imidazole derivatives as inhibitors of glutaminyl cyclase |
EP3461819B1 (en) | 2017-09-29 | 2020-05-27 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
US11813268B2 (en) | 2017-10-17 | 2023-11-14 | Albert Einstein College Of Medicine | Mitofusin activators and uses thereof |
EP3740466B1 (en) | 2018-01-17 | 2024-03-06 | Migal Galilee Research Institute Ltd. | New methionine metabolic pathway inhibitors |
EP3740482A1 (en) | 2018-01-17 | 2020-11-25 | Migal Galilee Research Institute Ltd. | New methionine metabolic pathway inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT84171B (pt) * | 1986-01-24 | 1989-03-30 | Sanofi Sa | Processo para a preparacao de derivados das n alfa-aril-sulfonilamiminoacil-p- -amidinofenil-alaninamidas, bem como dos seus derivados de sintese e das composicoes farmaceuticas que os contem |
PT84170B (pt) * | 1986-01-24 | 1989-03-30 | Sanofi Sa | Processo para a preparacao de derivados n alfa-substituidos das n alfa-aril-sulfonilaminoacil d-amidinofenil-alaninamidas |
DE3939797A1 (de) * | 1989-12-01 | 1991-06-06 | Basf Ag | Neue vom neuropeptid y abgeleitete peptide |
WO1992016549A1 (de) * | 1991-03-18 | 1992-10-01 | Pentapharm Ag | Para-substituierte phenylalanin-derivate |
JP3283114B2 (ja) * | 1992-09-07 | 2002-05-20 | クミアイ化学工業株式会社 | 縮合ヘテロ環誘導体及び農園芸用殺菌剤 |
-
1993
- 1993-02-15 FR FR9301686A patent/FR2701480B1/fr not_active Expired - Fee Related
-
1994
- 1994-02-09 PH PH47736A patent/PH30887A/en unknown
- 1994-02-14 HU HU9400414A patent/HUT66960A/hu unknown
- 1994-02-14 CA CA002115631A patent/CA2115631A1/en not_active Abandoned
- 1994-02-14 FI FI940680A patent/FI940680A/fi unknown
- 1994-02-14 NO NO940503A patent/NO304313B1/no unknown
- 1994-02-14 US US08/195,281 patent/US5506258A/en not_active Expired - Fee Related
- 1994-02-14 RU RU94004977A patent/RU2126382C1/ru active
- 1994-02-15 DE DE69418083T patent/DE69418083T2/de not_active Expired - Fee Related
- 1994-02-15 CN CN94102694A patent/CN1104634A/zh active Pending
- 1994-02-15 ES ES94400331T patent/ES2132351T3/es not_active Expired - Lifetime
- 1994-02-15 ZA ZA941029A patent/ZA941029B/xx unknown
- 1994-02-15 MX MX9401191A patent/MX9401191A/es not_active IP Right Cessation
- 1994-02-15 NZ NZ250878A patent/NZ250878A/en unknown
- 1994-02-15 DK DK94400331T patent/DK0614911T3/da active
- 1994-02-15 AT AT94400331T patent/ATE179430T1/de not_active IP Right Cessation
- 1994-02-15 TW TW083101254A patent/TW372233B/zh active
- 1994-02-15 JP JP6018511A patent/JP2994546B2/ja not_active Expired - Lifetime
- 1994-02-15 KR KR1019940002676A patent/KR940019682A/ko not_active Application Discontinuation
- 1994-02-15 EP EP94400331A patent/EP0614911B1/fr not_active Expired - Lifetime
- 1994-02-15 IL IL10864994A patent/IL108649A/en not_active IP Right Cessation
- 1994-02-15 AU AU55165/94A patent/AU673398B2/en not_active Ceased
-
1996
- 1996-01-04 US US08/582,887 patent/US5674890A/en not_active Expired - Fee Related
-
1999
- 1999-05-19 GR GR990401334T patent/GR3030243T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
IL108649A0 (en) | 1994-05-30 |
DK0614911T3 (da) | 1999-11-08 |
FR2701480A1 (fr) | 1994-08-19 |
KR940019682A (ko) | 1994-09-14 |
HUT66960A (en) | 1995-01-30 |
DE69418083T2 (de) | 1999-11-25 |
NO940503L (es) | 1994-08-16 |
JP2994546B2 (ja) | 1999-12-27 |
TW372233B (en) | 1999-10-21 |
NO940503D0 (no) | 1994-02-14 |
EP0614911A1 (fr) | 1994-09-14 |
EP0614911B1 (fr) | 1999-04-28 |
CA2115631A1 (en) | 1994-08-16 |
DE69418083D1 (de) | 1999-06-02 |
NZ250878A (en) | 1996-02-27 |
GR3030243T3 (en) | 1999-08-31 |
RU2126382C1 (ru) | 1999-02-20 |
US5674890A (en) | 1997-10-07 |
ATE179430T1 (de) | 1999-05-15 |
FI940680A0 (fi) | 1994-02-14 |
AU5516594A (en) | 1994-08-18 |
HU9400414D0 (en) | 1994-05-30 |
ZA941029B (en) | 1995-08-15 |
JPH06293794A (ja) | 1994-10-21 |
PH30887A (en) | 1997-12-23 |
NO304313B1 (no) | 1998-11-30 |
CN1104634A (zh) | 1995-07-05 |
FI940680A (fi) | 1994-08-16 |
MX9401191A (es) | 1994-08-31 |
US5506258A (en) | 1996-04-09 |
FR2701480B1 (fr) | 1995-05-24 |
IL108649A (en) | 1998-09-24 |
AU673398B2 (en) | 1996-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2132351T3 (es) | Compuestos con un grupo sulfamoilo y amidino, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
AR025225A1 (es) | Feniloxazolidinonas heterociclicas biciclicas sustituidas antibacterianas y composiciones farmacéuticas | |
ES2127858T3 (es) | Composicion suavizante de tipo acuoso para tejidos, nueva sal de amonio cuaternario y procedimiento para la preparacion de dicha sal. | |
PE20030226A1 (es) | Compuestos arilicos sustituidos con quinuclidinas para el tratamiento de enfermedades | |
AR044909A1 (es) | Derivados de tiazolilpiperidina, procesos para su preparacion, composiciones farmaceuticas que los comprenden y aplicaciones de dichos derivados en el tratamiento de hipertrigliceridemia , hipercolesterolemia y dislipidemia | |
AR025386A1 (es) | Moduladores de los receptores activados del proliferador de peroxisomas | |
CY1106522T1 (el) | Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο | |
UY26958A1 (es) | Nuevos agentes anticolinérgicos que se pueden emplear como medicamentos así como procedimiento para su preparación | |
UY28848A1 (es) | Antagonistas de cgrp seleccionados, procedimientos para su preparación, y su empleo como medicamentos | |
GT200100137A (es) | Pro-drogas de derivados de 4-fenil-piridina. | |
AR088808A2 (es) | Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica | |
MX9207074A (es) | Piperazinil- y piperidinil -ciclohexanoles y composicion farmaceutica que los comprende | |
AR047076A1 (es) | Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas | |
ES2039242T3 (es) | Un procedimiento para la preparacion de nuevos derivados de piperidina. | |
AR042941A1 (es) | Derivados de tiazol, su preparacion, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos inhibidores de la proteina-1 de adhesion vascular (vap-1) | |
PA8495101A1 (es) | Derivados de 13-metileritromicina | |
AR009070A1 (es) | Compuestos derivados de amidinas heterociclicas de cinco miembros, su uso y compuestos intermediarios utiles para la produccion de los mismos. | |
AR026352A1 (es) | Derivados de imidazopiridina como inhibidores de la fosfodiesterasa vii. | |
AR005532A1 (es) | Compuestos de dihalopropeno, las composiciones insecticidas/acaricidas que los contienen y los intermediarios de sintesis de dichos compuestos | |
ES2070002T3 (es) | Composiciones terapeuticas a base de derivados de 1,2-ditiol-3-tiona. | |
AR044275A1 (es) | Uso de derivados de sulfonamidas para la fabricacion de un medicamento para la profilaxis y/o tratamiento de las disfunciones alimentarias | |
AR054414A1 (es) | Compuestos espiro-hidantoina sustituidos con piridilo. composiciones farmaceuticas. | |
ES2029879T3 (es) | Procedimiento para producir derivados de aminas sustituidas. | |
ES2061530T3 (es) | 9-amino-1,4-etano-1,2,3,4-tetrahidroacridina y compuestos afines, intermediarios y un procedimiento para la preparacion de los mismos y su uso como medicamentos. | |
AR027454A1 (es) | Derivados de beta-alanina, utiles como antagonistas de receptores, las composiciones farmaceuticas que las contienen y el uso de los mismos para lapreparacion de medicamentos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 614911 Country of ref document: ES |